Haemonetics Corp. (hae 2.5 06/01/29)

13F holders, Q1 2026 (March 31)
10holders
2new positions
1sold out
$0.95avg. 13F price*

At the end of Q1 2026, 10 institutions reported holding Haemonetics Corp. (hae 2.5 06/01/29) in their 13F filings, unchanged from Q4 2025. 2 opened new positions and 1 sold out. The largest holders were Ssi Investment Management LLC ($5.0M), Income Research & Management ($3.1M) and State of Wisconsin Investment Board ($2.9M).

Company
Haemonetics Corp. (hae 2.5 06/01/29)
CUSIP
405024AD2
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q2 2025: 6Q2 2025Q3 2025: 7Q3 2025Q4 2025: 10Q4 2025Q1 2026: 10Q1 2026Q2 2026: 12Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$5.0M
Exits1$1.4M

All 13F filers, Q4 2025 → Q1 2026: 5,266,000 shares bought and 1,340,000 shares sold, net +3,926,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Ssi Investment Management LLC 0.41% New 5,250,000 $5.0M
Income Research & Management 1.86% No change 3,270,000 $3.1M
State of Wisconsin Investment Board 0.01% No change 3,000,000 $2.9M
Bank of New York Mellon Corp 0.00% No change 650,000 $620K
Cetera Investment Advisers 0.00% No change 86,000 $82K
&partners 0.00% No change 79,000 $75K
Choreo, LLC 0.00% No change 33,000 $32K
Foresight Capital Management Advisors, Inc. 0.01% No change 27,000 $26K
Mariner, LLC 0.00% New 16,000 $15K
Oddo BHF Asset Management Sas 0.00% No change 175 $168

"% of holder's portfolio" is HAEMONETICS CORP (HAE 2.5 06/01/29)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 2.5 06/01/29) the manager owns.